Cyclica is a neo-biotech.

Together with our partners, we’re building the biotech pipeline of the future.

Our pipeline

The biotech pipeline of the future isn’t owned or built by a single organization.

Cyclica is building a connected ecosystem through our work with early stage biotechs and big pharma alike.

Our ability to get new medicines to patients in need depends less on a breakthrough in technology than it does a breakthrough in how we collaborate.

World class teams rooted in science using superior technology won’t change the world alone. A fundamentally new business model is still needed. 

We are building a connected ecosystem through our work with early stage biotechs and big pharma alike. Our pipeline is based on making data-driven decisions about molecule design by applying machine learning to protein biophysics.

Whether our partners are a startup or a large multi-national company, we accelerate and de-risk drug discovery with our team and our technology while also catalyzing new types of business relationships.

ABOUT OUR MODEL

Integrated partnerships

Through our work with early stage biotechs and large tier one pharma alike, we are decentralizing innovation with technology, building novel data-driven pipelines, and instigating cross-organizational collaborations at a molecular level.

ALIGNED INTERESTS

Best of both worlds

For our large biotech and pharma customers, we help enrich existing portfolios, building custom models that deliver IP-grade, proprietary insights with breakthrough efficiency and precision. 

Separately, across a portfolio of more than 50 joint ventures and growing, we work at the vanguard of a wide variety of therapeutic areas to help get new medicines to patients faster and more precisely.

Partner with Cyclica

We set an ultra-high bar and live by it everyday. We’d love to help advance your impact.

Associated with an academic institute?

You can apply for in-kind access to the Ligand Design or Ligand Express platform.